IMMUNOGENIC PEPTIDES FOR APPLICATION FOR PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES, THE IMMUNE RESPONSES TO ALLOGENEIC FACTORS, ALLERGIC DISEASES, TUMOUR, TRANSPLANT REJECTION AND IMMUNE RESPONSES AGAINST VIRAL VECTORS USED FOR GENETIC THERAPY OR GENETIC VACCINATION Russian patent published in 2017 - IPC C07K4/02 C07K4/04 C07K4/12 C07K14/435 C07K14/05 C07K14/195 C12N5/783 A61K38/03 A61K38/17 A61K35/15 A61P37/06 

Abstract RU 2615460 C2

FIELD: biotechnology.

SUBSTANCE: invention relates to new peptides containing epitopes recognized by CD4+ natural killer T(NKT)-cells, and may be used in medicine. An immunogenic fusion peptide binding CD1d and containing [FWHY]-xx-[ILMV]-xx-[FWHY] and [CST]-xx-C or C-xx-[CST] motifs.

EFFECT: invention allows to increase the activity of cells for use in case of infectious diseases, autoimmune diseases, immune reaction to allogeneic factors introduction, allergic diseases, for tumour therapy, for transplant rejection prevention and for prevention of immunization against viral proteins.

20 cl, 4 dwg, 8 ex

Similar patents RU2615460C2

Title Year Author Number
MODIFIED EPITOPES FOR AMPLIFYING RESPONSES OF CD4+ T-CELLS 2013
  • Sen-Remi Zhan-Mari
RU2724994C2
MODULATION OF ANTIGEN IMMUNOGENICITY BY DELETING EPITOPES RECOGNIZED BY NKT-CELLS 2011
  • Sen-Remi Zhan-Mari
RU2598247C2
NEW IMMUNOGENIC PEPTIDES 2015
  • Saint-Remy Jean-Marie
  • Carlier Vincent
  • Vander Elst Luc
  • Burkhart David
RU2709711C2
MODULATION OF ANTIGEN IMMUNOGENICITY BY ADDITION OF EPITOPES RECOGNIZED BY NKT CELLS 2011
  • Sen-Remi Zhan-Mari
RU2603075C2
COAGULATION FACTOR VIII WITH REDUCED IMMUNOGENICITY 2013
  • Sen-Remi Zhan-Mari
RU2631801C2
PEPTIDES AND DIABETES TREATMENT METHODS 2018
  • Vander Elst, Luc
  • Carlier, Vincent
  • Saint-Remy, Jean-Marie
RU2761653C2
IMMUNOSTIMULATOR INDUCING TUMOR-SPECIFIC IMMUNE CELLULAR RESPONSE AND METHOD FOR ITS PREPARING 1996
  • Shmidt Val'Ter
  • Birnshtil' Maks
  • Shvajgkhoffer Tamash
  • Shtajnljajn Peter
  • Bushle Mikhaehl'
RU2206329C2
ENHANCING IMMUNE RESPONSE AND TARGET FOCUS BY ANTIGENS AND/OR DRUG 2008
  • Serra Vensan
RU2548685C2
T-CELLS WITH TRANSDUCED ANTIGEN APPLIED AS ANTIGEN DELIVERY SYSTEMS 2003
  • Traversari Katja
  • Bordin'On Klaudio
RU2330884C2
DNA COMPOSITION FOR INDUCING IMMUNE RESPONSE ON TUMOUR-ASSOCIATED MACROPHAGUES 2007
  • Rejsfeld Ral'F A.
  • Sjan Zhun
  • Lo Jun'Pin
RU2459631C2

RU 2 615 460 C2

Authors

Sen-Remi Zhan-Mari

Dates

2017-04-04Published

2011-11-24Filed